Last reviewed · How we verify

NCT06982430: ERRC

Early Recurrence of Renal Colic: Predictive Factors

Completed Last updated 21 May 2025
What this trial tests

trial testing phone call in Renal Colic in 878 participants. Completed in 31 May 2024.

Timeline
1 January 2022
Primary endpoint
31 May 2024
31 May 2024

Quick facts

Lead sponsorUniversity of Monastir
StatusCompleted
Study typeOBSERVATIONAL
Enrollment878
Start date1 January 2022
Primary completion31 May 2024
Estimated completion31 May 2024
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

University of Monastir

Who can join

18 and older, any sex, with Renal Colic or Emergency Department Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Renal colic (RC) is a common pathology in emergency medicine, with a high risk of recurrence. Early recurrence remains a major concern, affecting up to 30% of patients, with around 84% of these recurrences occurring within two days of the initial episode , despite preventive measures, both pharmacological and non-pharmacological . The recurrence of RC varies significantly between individuals, and systematic evaluation may facilitate personalized treatment . Recurrence is likely influenced by multiple factors, and identifying these could help clinicians develop better preventive strategies.The main aim of our study was to identify factors predictive of early recurrence of RC pain after emergency department (ED) management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of phone call

Trials testing the same drug.

Other recruiting trials for Renal Colic

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06982430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing